Testing effectiveness (Phase 2)Study completedNCT04889209
What this trial is testing
Delayed Heterologous SARS-CoV-2 Vaccine Dosing (Boost) After Receipt of EUA Vaccines
Who this might be right for
COVID-19
National Institute of Allergy and Infectious Diseases (NIAID) 867